Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trial.

@article{Sive2012OutcomesIO,
  title={Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trial.},
  author={Jonathan I Sive and Georgina A. N. Buck and Adele K Fielding and Hillard M Lazarus and Mark R Litzow and Selina M. Luger and David Ian Marks and A K Mcmillan and Anthony V Moorman and S. M. Richards and Jacob M. Rowe and Martin S. Tallman and Anthony H. Goldstone},
  journal={British journal of haematology},
  year={2012},
  volume={157 4},
  pages={463-71}
}
Although the incidence rate of acute lymphoblastic leukaemia (ALL) is slightly higher in older than in younger adults, response rates to induction chemotherapy and survival rates are poorer. The contribution of disease-related versus treatment-related factors remains unclear. We analysed 100 older patients (aged 55-65 years) treated on the UKALLXII/ECOG2993… CONTINUE READING